Position history for Boston Trust Walden Corp's holdings in HAEMONETICS CORP MASS
Boston Trust Walden Corp holds 501,885 shares of HAE (HAEMONETICS CORP MASS), worth $28.3M as of 2026-Q1. The position was decreased (-13.6% shares). HAE represents 0.2% of Boston Trust Walden Corp's portfolio.
Current Value
$28.3M
Current Shares
501,885
Total Value Change
-$30.6M
Total Shares Change
-209,704
Other major holders of HAE: Capital Research Global Investors
Decreased |
| 501,885 |
-13.6% |
| $28.3M |
| 0.2% |
| $65.63 |
0 |
| 2025-Q4 | Decreased | 580,650 | -39.3% | $46.5M | 0.4% | $80.98 | 0 |
| 2025-Q3 | Decreased | 956,690 | -12.2% | $46.6M | 0.3% | $48.12 | 0 |
| 2025-Q2 | Decreased | 1.1M | -2.5% | $81.3M | 0.6% | $73.80 | 0 |
| 2025-Q1 | Increased | 1.1M | +22.1% | $71.1M | 0.5% | $63.19 | 50 |
| 2024-Q4 | Increased | 915,722 | +13.1% | $71.5M | 0.5% | $76.60 | 47 |
| 2024-Q3 | Increased | 809,608 | +13.8% | $65.1M | 0.5% | $79.80 | 40 |
| 2024-Q2 | Decreased | 711,589 | -0.0% | $58.9M | 0.4% | $82.73 | 0 |